Epigenetic control of microglial mitochondrial immunity by KAT7 drives Alzheimer's disease pathogenesis
This study identifies the histone acetyltransferase KAT7 as a critical epigenetic regulator that drives Alzheimer's disease pathogenesis by activating Cmpk2-mediated mitochondrial DNA synthesis and subsequent neuroinflammatory signaling in microglia, establishing KAT7 inhibition as a promising therapeutic strategy to reduce amyloid burden and restore cognitive function.